M&T Bank Corp Hutchmed (China) LTD Transaction History

M&T Bank Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$7.65 - $15.51 $602,223 - $1.22 Million	78,722 Added 681.1%	90,280 $1.33 Million
Q4 2022 Feb 13, 2023	SELL	$7.65 - $15.51 $602,223 - $1.22 Million	-78,722 Reduced 87.2%	11,558 $170,000
Q1 2022 May 09, 2022	SELL	$15.52 - $35.65 $15,582 - $35,792	-1,004 Reduced 1.1%	90,280 $1.71 Million
Q4 2021 Feb 07, 2022	SELL	$28.89 - $35.33 $349,684 - $427,634	-12,104 Reduced 11.71%	91,284 $3.2 Million
Q3 2021 Oct 28, 2021	SELL	$35.66 - $42.94 $5,348 - $6,441	-150 Reduced 0.14%	103,388 $3.79 Million
Q2 2021 Aug 13, 2021	SELL	$23.7 - $39.27 $33,772 - $55,959	-1,425 Reduced 1.36%	103,538 $4.07 Million
Q1 2021 May 06, 2021	BUY	$27.01 - $36.8 $403,853 - $550,233	14,952 Added 16.61%	104,963 $2.97 Million
Q4 2020 Feb 12, 2021	BUY	$27.51 - $34.36 $412 - $515	15 Added 0.02%	90,011 $2.88 Million
Q3 2020 Nov 06, 2020	SELL	$25.8 - $34.61 $249,795 - $335,094	-9,682 Reduced 9.71%	89,996 $2.91 Million
Q2 2020 Jul 29, 2020	BUY	$17.65 - $28.05 $52,191 - $82,943	2,957 Added 3.06%	99,678 $2.75 Million
Q1 2020 May 14, 2020	BUY	$15.19 - $29.51 $190,330 - $369,760	12,530 Added 14.88%	96,721 $1.73 Million
Q4 2019 Feb 07, 2020	BUY	$17.17 - $25.95 $130,835 - $197,739	7,620 Added 9.95%	84,191 $2.11 Million
Q3 2019 Nov 12, 2019	BUY	$17.84 - $22.69 $1.37 Million - $1.74 Million	76,571 New	76,571 $1.37 Million

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.47B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.